Pharmaceutical company Galderma (UK) Limited has begun a review of its distribution arrangements and announced plans to appoint one preferred distributor for its Azzalure and Restylane brands.
The British College of Aesthetic Medicine has published its annual survey results for 2017-2018, covering botulinum toxin, dermal filler and laser treatments.
A UK study conducted by Mintel of 1,008 female internet users has found that over the last year, almost three in 10 (28%) women have reduced the number of products in their skincare routine. It also revealed that 54% of millennials were the most likely to have simplified their routines.
A survey conducted by the British Skin Foundation has suggested that 77% of British dermatologists agree that sunbeds should be banned in the UK.
A survey of 2,000 American men and women, conducted by dermatology company Galderma, suggests 74% would be more interested in treatments if they produced natural as opposed to frozen results.
Millennials appear to be driving the UK’s interest in aesthetic procedures, according to a new survey of 1,030 UK adults over the age of 18.
A new survey has shed light on the significant impact of COVID-19, with 49% of aesthetic practitioners reporting that they risk going out of business as a result of the pandemic.
The US Food and Drug Administration (FDA) has approved hyaluronic acid dermal filler Restylane Lyft for cheek augmentation and the correction of age-related mid-face contour deficiencies via small blunt tip cannula in patients over the age of 21.
A national study held by law firm Cosmetic Surgery Solicitors suggests that women with C cup breasts feel most positively about their breasts than those with any other size breasts.
Due to unforeseen circumstances, The Anatomy of the Smile Webinar sponsored by pharmaceutical company Galderma has been postponed until March 11.